Selected research
Industry Research
Transconjunctival Sutureless Vitrectomy (TSV) Industry Research Report 2026
Market perspective
The global Transconjunctival Sutureless Vitrectomy (TSV) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Transconjunctival Sutureless Vitrectomy (TSV) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Transconjunctival Sutureless Vitrectomy (TSV) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Transconjunctival Sutureless Vitrectomy (TSV) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Transconjunctival Sutureless Vitrectomy (TSV) include Bascom Palmer Eye Institute, Moorfields Eye Hospital, Massachusetts Eye and Ear Infirmary, Sichuan Provincial People's Hospital, Tongji Hospital Affiliated to Tongji University and Tianjin Medical University Eye Hospital, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Transconjunctival Sutureless Vitrectomy (TSV) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transconjunctival Sutureless Vitrectomy (TSV).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transconjunctival Sutureless Vitrectomy (TSV) Market by Company
Bascom Palmer Eye Institute
Moorfields Eye Hospital
Massachusetts Eye and Ear Infirmary
Sichuan Provincial People's Hospital
Tongji Hospital Affiliated to Tongji University
Tianjin Medical University Eye Hospital
Transconjunctival Sutureless Vitrectomy (TSV) Segment by Type
25G
23G
Transconjunctival Sutureless Vitrectomy (TSV) Segment by Application
Ophthalmology
Others
Transconjunctival Sutureless Vitrectomy (TSV) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transconjunctival Sutureless Vitrectomy (TSV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transconjunctival Sutureless Vitrectomy (TSV) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transconjunctival Sutureless Vitrectomy (TSV).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transconjunctival Sutureless Vitrectomy (TSV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 25G
- 23G
Applications
- Ophthalmology
- Others
Companies covered
- Bascom Palmer Eye Institute
- Moorfields Eye Hospital
- Massachusetts Eye and Ear Infirmary
- Sichuan Provincial People's Hospital
- Tongji Hospital Affiliated to Tongji University
- Tianjin Medical University Eye Hospital
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Transconjunctival Sutureless Vitrectomy (TSV) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 25G
- 2.2.3 23G
- 2.3 Transconjunctival Sutureless Vitrectomy (TSV) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Ophthalmology
- 2.3.3 Others
- 2.4 Assumptions and Limitations
3 Transconjunctival Sutureless Vitrectomy (TSV) Breakdown Data by Type
- 3.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Historic Market Size by Type (2021-2026)
- 3.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Forecasted Market Size by Type (2027-2032)
4 Transconjunctival Sutureless Vitrectomy (TSV) Breakdown Data by Application
- 4.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Historic Market Size by Application (2021-2026)
- 4.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Perspective (2021-2032)
- 5.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Growth Trends by Region
- 5.2.1 Global Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Transconjunctival Sutureless Vitrectomy (TSV) Historic Market Size by Region (2021-2026)
- 5.2.3 Transconjunctival Sutureless Vitrectomy (TSV) Forecasted Market Size by Region (2027-2032)
- 5.3 Transconjunctival Sutureless Vitrectomy (TSV) Market Dynamics
- 5.3.1 Transconjunctival Sutureless Vitrectomy (TSV) Industry Trends
- 5.3.2 Transconjunctival Sutureless Vitrectomy (TSV) Market Drivers
- 5.3.3 Transconjunctival Sutureless Vitrectomy (TSV) Market Challenges
- 5.3.4 Transconjunctival Sutureless Vitrectomy (TSV) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Transconjunctival Sutureless Vitrectomy (TSV) Players by Revenue
- 6.1.1 Global Top Transconjunctival Sutureless Vitrectomy (TSV) Players by Revenue (2021-2026)
- 6.1.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Revenue Market Share by Players (2021-2026)
- 6.2 Global Transconjunctival Sutureless Vitrectomy (TSV) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Transconjunctival Sutureless Vitrectomy (TSV) Head Office and Area Served
- 6.4 Global Transconjunctival Sutureless Vitrectomy (TSV) Players, Product Type & Application
- 6.5 Global Transconjunctival Sutureless Vitrectomy (TSV) Manufacturers Established Date
- 6.6 Global Transconjunctival Sutureless Vitrectomy (TSV) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
- 7.2 North America Transconjunctival Sutureless Vitrectomy (TSV) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2021-2026)
- 7.4 North America Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
- 8.2 Europe Transconjunctival Sutureless Vitrectomy (TSV) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2021-2026)
- 8.4 Europe Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
- 9.2 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
- 10.2 South America Transconjunctival Sutureless Vitrectomy (TSV) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2021-2026)
- 10.4 South America Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Market Size (2021-2032)
- 11.2 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Transconjunctival Sutureless Vitrectomy (TSV) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bascom Palmer Eye Institute
- 12.1.1 Bascom Palmer Eye Institute Company Information
- 12.1.2 Bascom Palmer Eye Institute Business Overview
- 12.1.3 Bascom Palmer Eye Institute Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.1.4 Bascom Palmer Eye Institute Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.1.5 Bascom Palmer Eye Institute Recent Developments
- 12.2 Moorfields Eye Hospital
- 12.2.1 Moorfields Eye Hospital Company Information
- 12.2.2 Moorfields Eye Hospital Business Overview
- 12.2.3 Moorfields Eye Hospital Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.2.4 Moorfields Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.2.5 Moorfields Eye Hospital Recent Developments
- 12.3 Massachusetts Eye and Ear Infirmary
- 12.3.1 Massachusetts Eye and Ear Infirmary Company Information
- 12.3.2 Massachusetts Eye and Ear Infirmary Business Overview
- 12.3.3 Massachusetts Eye and Ear Infirmary Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.3.4 Massachusetts Eye and Ear Infirmary Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.3.5 Massachusetts Eye and Ear Infirmary Recent Developments
- 12.4 Sichuan Provincial People's Hospital
- 12.4.1 Sichuan Provincial People's Hospital Company Information
- 12.4.2 Sichuan Provincial People's Hospital Business Overview
- 12.4.3 Sichuan Provincial People's Hospital Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.4.4 Sichuan Provincial People's Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.4.5 Sichuan Provincial People's Hospital Recent Developments
- 12.5 Tongji Hospital Affiliated to Tongji University
- 12.5.1 Tongji Hospital Affiliated to Tongji University Company Information
- 12.5.2 Tongji Hospital Affiliated to Tongji University Business Overview
- 12.5.3 Tongji Hospital Affiliated to Tongji University Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.5.4 Tongji Hospital Affiliated to Tongji University Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.5.5 Tongji Hospital Affiliated to Tongji University Recent Developments
- 12.6 Tianjin Medical University Eye Hospital
- 12.6.1 Tianjin Medical University Eye Hospital Company Information
- 12.6.2 Tianjin Medical University Eye Hospital Business Overview
- 12.6.3 Tianjin Medical University Eye Hospital Revenue in Transconjunctival Sutureless Vitrectomy (TSV) Business (2021-2026)
- 12.6.4 Tianjin Medical University Eye Hospital Transconjunctival Sutureless Vitrectomy (TSV) Product Portfolio
- 12.6.5 Tianjin Medical University Eye Hospital Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst